News | June 03, 2013

Mevion Delivers Proton Technology to the Stephenson Cancer Center at Oklahoma University

This is the third Mevion S250 proton therapy system delivered

June 3, 2013 — Mevion Medical Systems has delivered the superconducting synchrocyclotron accelerator for its Mevion S250 proton therapy system under installation at the Peggy and Charles Stephenson Cancer Center at the University of Oklahoma.

This is the third single-room Mevion S250 proton therapy system delivered — all installed at leading academic institutions.

”We are delighted to receive this revolutionary machine that will allow us to deliver the same proton treatment as other larger conventional systems but at a fraction of the cost and size and with the most advanced clinical targeting technology” said Mike Samis, chairman of the University Hospitals Authority and Trust. “The addition of this advanced treatment option to our flagship cancer center continues to define the OU Cancer Institute as the state’s leading center of excellence.”

Following a five-day journey from Massachusetts to Oklahoma, the proton accelerator was brought into the Stephenson Cancer Center in only a few hours and will be installed on its gantry. The Mevion S250 is enhancing the center’s state-of-the-art radiation therapy department with a fully integrated proton therapy clinical treatment room. A second Mevion S250 treatment space has been reserved to support future clinical demand.

Powered by a TriNiobium Core, the Mevion S250 is a unique proton therapy system that provides the same precise, non-invasive treatment capabilities and advantages of conventional systems but with significantly reduced size, improved reliability, efficient clinical workflow and lower implementation and operational costs. With a footprint similar to an X-ray radiation therapy device, Mevion proton therapy can be easily integrated into any existing radiation therapy department.

For more information: www.mevion.com

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init